| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | 4.387 | 4.170 | 3.952 | 2.187 | 641 | 263 | 0 | 0 | 0 |
| Total Income - EUR | - | 4.387 | 4.170 | 3.952 | 2.187 | 641 | 263 | 0 | 0 | 0 |
| Total Expenses - EUR | - | 2.337 | 1.658 | 718 | 766 | 4.159 | 208 | 0 | 0 | 0 |
| Gross Profit/Loss - EUR | - | 2.050 | 2.512 | 3.234 | 1.421 | -3.518 | 55 | 0 | 0 | 0 |
| Net Profit/Loss - EUR | - | 1.919 | 2.387 | 3.115 | 1.355 | -3.537 | 47 | 0 | 0 | 0 |
| Employees | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Bellalexis Myrulexa Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | 600 | 119 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Assets | - | 1.408 | 4.257 | 7.423 | 8.582 | 4.878 | 4.819 | 4.834 | 4.819 | 4.792 |
| Inventories | - | 129 | 123 | 425 | 177 | 695 | 679 | 681 | 679 | 675 |
| Receivables | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash | - | 1.279 | 4.133 | 6.999 | 8.405 | 4.183 | 4.140 | 4.153 | 4.140 | 4.117 |
| Shareholders Funds | - | 1.963 | 4.317 | 7.353 | 8.566 | 4.866 | 4.805 | 4.820 | 4.806 | 4.779 |
| Social Capital | - | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | 44 | 58 | 70 | 16 | 11 | 14 | 14 | 14 | 14 |
| Income in Advance | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "9602 - 9602" | |||||||||
| CAEN Financial Year |
9602
|
|||||||||
Comments - Bellalexis Myrulexa Srl